0.8231

12.04% -0.1069

Dare Bioscience Inc (DARE)

Overview News Price History Financials Discussions Forecast Stock Split

Dare Bioscience Inc stock is traded at $0.8231, with a volume of 1.82M. It is down -12.04% in the last 24 hours and down -58.27% over the past month. Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

Previous Close:

$0.93

Open:

$0.929

24h Volume:

1.82M

Relative Volume:

4.77

Market Cap:

$12.52M

Revenue:

$1.16M

Net Income/Loss:

$-12.02M

P/E Ratio:

-0.7929

EPS:

-1.0381

Net Cash Flow:

$-10.16M

1W Performance:

-39.85%

1M Performance:

-58.27%

6M Performance:

-51.02%

1Y Performance:

-62.82%

1-Day Range:

$0.81

$0.93

1-Week Range:

$0.765

$1.61

52-Week Range:

$0.765

$3.78

Dare Bioscience Inc Stock (DARE) Company Profile

Name

Dare Bioscience Inc

Sector

Healthcare (1089)

Industry

Biotechnology (604)

Phone

858-926-7655

Address

3655 NOBEL DRIVE, SAN DIEGO, CA

Employee

Twitter

@DareBioscience

Next Earnings Date

2026-08-13

Latest SEC Filings

DARE's Discussions on Twitter

Compare DARE vs VRTX, REGN, ARGX, RVMD, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DARE Dare Bioscience Inc	0.8361	13.93M	1.16M	-12.02M	-10.16M	-1.0381
VRTX Vertex Pharmaceuticals Inc	515.76	128.19B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	805.65	82.72B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	990.87	53.26B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	211.83	43.66B	742.00K	-1.37B	-1.07B	-7.0731
ONC Beone Medicines Ltd Adr	362.63	39.31B	5.76B	514.49M	1.10B	4.4813

Dare Bioscience Inc Stock (DARE) Latest News

09:33 AM

Form 8K Dare Bioscience Inc For: 17 August By Investing.com - Investing.com Canada

09:33 AM

08:43 AM

Daré Bioscience Raises ~$6 Million in Equity Offering at $1.37 With Attached Warrants - TradingView

08:43 AM

07:43 AM

H.C. Wainwright reiterates Dare Bioscience stock rating at buy By Investing.com - Investing.com India

07:43 AM

Aug 15, 2026

symbol__ Stock Quote Price and Forecast - CNN

Aug 15, 2026

Q2 2026 Dare Bioscience Inc Earnings Call Transcript - GuruFocus

Aug 15, 2026

Aug 14, 2026

H.C. Wainwright Maintains Dare Bioscience(DARE.US) With Buy Rating, Maintains Target Price $12 - Moomoo

Aug 14, 2026

Daré Bioscience raises $6M in registered direct offering By Investing.com - Investing.com India

Aug 14, 2026

Dare Bioscience Prices $6 Million Registered Direct Offering; Shares Fall - marketscreener.com

Aug 14, 2026

Daré Bioscience raises $6M in registered direct offering - Investing.com

Aug 14, 2026

Daré Bioscience Announces $6.0 Million Registered Direct Offering and Concurrent Private Placement - Moomoo

Aug 14, 2026

Dare Bioscience earnings beat by $0.11, revenue topped estimates - Investing.com Canada

Aug 14, 2026

Aug 13, 2026

Daré Bioscience (DARE) Launches New Product Amid Challenging Val - GuruFocus

Aug 13, 2026

Dare Bioscience (DARE) Q2 Results Highlight Challenges Amid Low Valuation on Price-to-Sales Basis - GuruFocus

Aug 13, 2026

Earnings call transcript: Daré Bioscience Q2 2026 loss narrows as stock jumps after hours - Investing.com

Aug 13, 2026

Dare Bioscience Reports Q2 2026 Results: Full Earnings Call Transcript - Benzinga

Aug 13, 2026